Acute myocardial infarction is now considered more treatable than ever. However, despite optimized reperfusion, modern pharmacotherapies and improved care systems, one risk remains that is underestimated in many clinical procedures: the development of new heart failure after surviving an infarction. A recent analysis by a large US healthcare system shows that post-infarction heart failure occurs more frequently than a new myocardial infarction – and significantly affects the prognosis of those affected.
You May Also Like
- Omaveloxolone for Friedreich's Ataxia
Efficacy and Safety Studied Over 6 Years
- Psoriasis: therapy with biologics and TYK-2-i
Progress assessments based on current long-term and real-world data
- Hypertension: the most important facts for daily practice
Early dual antihypertensive therapy is usually indicated
- Escitalopram for anxiety disorders
Positive effect, but no immediate improvement in symptoms
- Helicobacter pylori infection
Simplified dual therapy beats quadruple regimen
- Gastric carcinoma
Ways of precision oncology
- Endometrial Cancer
Immunological drivers and new therapeutic pathways
- Exercise for type 1 diabetes